<DOC>
	<DOCNO>NCT01219933</DOCNO>
	<brief_summary>This open-label , single-arm study ass use glucocorticoid ( GC ) daily clinical practice evaluate dose reduction glucocorticoid low disease activity achieve patient rheumatoid arthritis tre ated GC background RoActemra/Actemra ( tocilizumab ) 8mg/kg intravenously every 4 week . In non-interventional phase , use GC daily clinical Belgian practice evaluate describe . This period maximum 6 mont h allow patient obtain inclusion criterion secondary interventional phase . In interventional phase , systematic GC dose reductio n schedule evaluate patient achieve low disease activity wh ile receive background therapy RoActemra/Actemra 8 mg/kg . Methyl prednisolone give start dose &gt; /= 1 mg &lt; /=20 mg orally aily taper . The anticipated study duration 13 month</brief_summary>
	<brief_title>A Study Glucocorticoid Use Evaluate Systematic Methylprednisolone Reduction Patients With Rheumatoid Arthritis Background RoActemra/Actemra ( Tocilizumab ) ( ACT-ALONE )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<criteria>Noninterventional phase Adult patient , &gt; /=18 year age Moderate severe active rheumatoid arthritis define Disease Activity Score use 28joint count ( DAS28 ) &gt; /=5.1 Patients inadequate clinical response current treatment 2 nonbiologic diseasemodifying antirheumatic drug ( DMARDs ) , one methotrexate ( MTX ) optimally administer period 3 month inadequate response current antiTNF therapy Current use oral glucocorticoid start least 4 week prior enrolment Interventional phase Patients enrol noninterventional phase Patients low disease activity define DAS28 &lt; /=3.2 Visit 2 Use oral glucocorticoid methylprednisolone equivalent dose &gt; /=1mg &lt; /=20mg/day Visit 2 Noninterventional &amp; interventional phase Rheumatic autoimmune disease rheumatoid arthritis , significant systemic involvement secondary rheumatoid arthritis Functional class IV define American College Rheumatology ( ACR ) Classification Functional Status rheumatoid arthritis Prior history current inflammatory joint disease rheumatoid arthritis ( e.g . gout )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>